Vaxxinity Inc 's ROA from the fourth quarter of 2023 to the fourth quarter of 2022 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Vaxxinity Inc 's ROA in the fourth quarter of 2023?
Vaxxinity Inc recorded a cumulative net loss of $-57 million during 12 months ending in the fourth quarter of 2023, resulting in a negative return on assets (ROA) of -88.04%.

However, within the Healthcare sector 919 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the third quarter of 2023 from 4807 to 5406.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Dec 31 2023) IV. Quarter	(Sep 30 2023) III. Quarter	(Jun 30 2023) II. Quarter	(Mar 31 2023) I. Quarter	(Dec 31 2022) IV. Quarter
Y / Y Total Assets Change	-58.35 %	-53.25 %	-49.24 %	-41.99 %	-36.99 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-57	-66	-72	-75	-75
Return On Assets (TTM)	-88.04 %	-82.3 %	-74.67 %	-66.2 %	-58.15 %
VAXX's Total Ranking	# 5406	# 4807	# 4859	# 4926	# 5599
Total Assets (TTM) in million	44	57	71	86	106
Seq. Total Assets Change	-22.91 %	-19.46 %	-16.56 %	-19.61 %	-13.47 %
Seq. Net Income Change	-	-	-	-	-

VAXX's 5 Years Annual ROA >> Back to VAXX Management Effectiveness >> Compare VAXX ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 430
Sector	# 920
Overall	# 5285

Return On Assets Statistics
High	Average	Low
-58.55 %	-85.81 %	-117.85 %
(Dec 31 2022)		(Jun 30 2022)

Financial Statements
Vaxxinity Inc 's Assets	$ 44 million	VAXX's Balance sheet
Vaxxinity Inc 's Income	$ -11 million	Quarterly VAXX's Income Statement
VAXX's Income by Division		See VAXX's Income by Division

Annual Return On Assets	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021	FY	FY
Y / Y Total Assets Change	-58.35 %	-36.16 %	-	-	-
Total Assets in million	44	106	167	0	0
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	-57	-75	-137	0	0
Annual Return On Assets	-128.49 %	-70.7 %	-82.3 %	-	-

VAXX's 5 Years Annual ROA >> Back to VAXX Management Effectiveness >> Compare VAXX ROA to its Competitors

More Return On Assets Ratios
VAXX's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
VAXX's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for VAXX's Competitors
Subscribers only: Roa for Vaxxinity Inc 's Suppliers
Subscribers only: Return On Assets for VAXX's Customers

You may also want to know
VAXX's Roi	VAXX's Inventory Turnover Ratio	VAXX's Growth Rates	VAXX's Dividend Comparisons
	VAXX's Profitability Ratios	VAXX's Asset Turnover Ratio	VAXX's Dividend Growth
VAXX's Roe	VAXX's Valuation Ratios	VAXX's Financial Strength Ratios	VAXX's Dividend Payout Ratio

Companies with similar Return On Assets at Dec 31 2023, within Healthcare Sector

ROA

Date modified: 2026-09-08T15:11:13+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.